Author: Elizabeth Gregerson

Memorial Sloan Kettering Cancer Center in New York City has appointed two oncology chiefs. 

Individuals are at an increased risk of cardiovascular disease and psychological illness after a family member is diagnosed with cancer, according to a study published Sept. 9 in Cancer.

University of Texas MD Anderson Cancer Center and Rice University, both based in Houston, have partnered to launch a new operational research initiative aimed at improving cancer care operations with data. 

Surgeons at the Camden, N.J.-based MD Anderson Cancer Center at Cooper employed noninvasive, histotripsy technology for the treatment of liver cancer, becoming one of 20 cancer centers in the world to offer the treatment. 

A team from Memorial Sloan Kettering Cancer Center in New York City identified a new, rare form of small cell lung cancer, found primarily in patients who have no history of smoking.

Flagstaff-based Northern Arizona Healthcare has partnered with Phoenix-based City of Hope to offer advanced treatment options and expertise to NAH patients with complex or rare types of cancer closer to home. 

The American Society of Clinical Oncology has publicly urged CMS to ensure patient access to CAR T-cell therapy in response to the agency's proposed 2025 Hospital Outpatient Prospective Payment System plan.

Abhisek Swaika, MD, has been named the medical director of the Northwell Health Cancer Institute at Rego Park in New York City. 

Cancer continued to be underdiagnosed after the first year of the COVID-19 pandemic, according to a study published Sept. 6 in JAMA Network Open.

New Orleans-based Ochsner Health was met with some uncertainty when it launched its pharmacogenomic program in March 2022 and became one of the first health systems to standardize genomic testing.